Development of Gastro Retentive Drug Delivery System of Cephalexin by using Factorial Design

The objective of this research work was to formulate and optimize the floating drug delivery system containing cephalexin using 2 3 factorial design. Floating tablets were prepared by direct compression method incorporating HPMC K4M, xanthan gum, guar gum, sodium bicarbonate and tartaric acid as gas generating agent. The influence of independent variables like, polymer: polymer ratio, polymer type and tartaric acid on floating lag time and cephalexin release profile were studied. The diffusion exponent (n) of Krosmeyer Peppas for optimized formulation was found to be 0.635 which indicates the mechanism of drug release was anomalous transport. Floating lag time of optimized formulation was 1.50 min and remained buoyant for 24 hrs. Optimized formulation was checked for stability at 40oC / 75% RH which was found to be stable. Scanning electron microscopy study revealed gel formation. FT-IR studies revealed that there was no chemical interaction between cephalexin and other excipients.

[1]  K. Florey,et al.  Analytical profiles of drug substances , 1972 .

[2]  Ankit Jain,et al.  Floating Drug Delivery Systems: A Review , 2011 .

[3]  V. Lenaerts,et al.  Bioadhesive Drug Delivery Systems , 1989 .

[4]  J. Siepmann,et al.  Floating matrix tablets based on low density foam powder: effects of formulation and processing parameters on drug release. , 2003, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[5]  J. Irache,et al.  Specific and non-specific bioadhesive particulate systems for oral delivery to the gastrointestinal tract. , 1998, Advanced drug delivery reviews.

[6]  E. Lai,et al.  Molecularly imprinted solid phase extraction-pulsed elution-mass spectrometry for determination of cephalexin and alpha-aminocephalosporin antibiotics in human serum. , 2004, Journal of pharmaceutical and biomedical analysis.

[7]  P. Maincent,et al.  Evaluation of peroral silicone dosage forms in humans by gamma-scintigraphy. , 1999, Journal of controlled release : official journal of the Controlled Release Society.

[8]  F. Oehme Goodman and Gilman 's: The pharmacological basis of therapeutics , 1996 .

[9]  J. Fell,et al.  Amoxycillin release from a floating dosage form based on alginates. , 2000, International journal of pharmaceutics.

[10]  F. N. Christensen,et al.  The effect of density on the gastric emptying of single- and multiple-unit dosage forms , 1986, Pharmaceutical Research.

[11]  Mm Patel,et al.  Spectrophotometric methods for the estimation of Cephalexin in tablet dosage forms , 2006 .

[12]  Ira,et al.  Floating drug delivery systems: A review , 2005, AAPS PharmSciTech.

[13]  P. Vavia,et al.  Development of sustained release gastroretentive drug delivery system for ofloxacin: in vitro and in vivo evaluation. , 2005, International journal of pharmaceutics.

[14]  C. Rhodes,et al.  Controlled-Release Drug Delivery Systems for Prolonged Gastric Residence: An Overview , 1996 .

[15]  J. B. Park,et al.  Preparation of alginate beads for floating drug delivery system: effects of CO(2) gas-forming agents. , 2002, International journal of pharmaceutics.

[16]  K. Amighi,et al.  Development and evaluation of new multiple-unit levodopa sustained-release floating dosage forms. , 2007, International journal of pharmaceutics.

[17]  C. Rhodes,et al.  Development of a Novel Controlled-Release System for Gastric Retention , 1997, Pharmaceutical Research.

[18]  A. Babbar,et al.  Formulation and development of floating capsules of celecoxib: In vitro and in vivo evaluation , 2007, AAPS PharmSciTech.